- Home
- SNBR vs EDIT Comparison
SNBR vs EDIT Comparison
Compare SNBR & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- EDIT
- Stock Information
- Founded
- SNBR 1987
- EDIT 2013
- Country
- SNBR United States
- EDIT United States
- Employees
- SNBR 4145
- EDIT N/A
- Industry
- SNBR Home Furnishings
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNBR Consumer Discretionary
- EDIT Health Care
- Exchange
- SNBR Nasdaq
- EDIT Nasdaq
- Market Cap
- SNBR 261.1M
- EDIT 327.0M
- IPO Year
- SNBR 1998
- EDIT 2016
- Fundamental
- Price
- SNBR $12.34
- EDIT $2.39
- Analyst Decision
- SNBR Hold
- EDIT Buy
- Analyst Count
- SNBR 3
- EDIT 13
- Target Price
- SNBR $12.83
- EDIT $9.38
- AVG Volume (30 Days)
- SNBR 513.8K
- EDIT 2.0M
- Earning Date
- SNBR 10-30-2024
- EDIT 11-04-2024
- Dividend Yield
- SNBR N/A
- EDIT N/A
- EPS Growth
- SNBR N/A
- EDIT N/A
- EPS
- SNBR N/A
- EDIT N/A
- Revenue
- SNBR $1,734,997,000.00
- EDIT $61,759,000.00
- Revenue This Year
- SNBR N/A
- EDIT N/A
- Revenue Next Year
- SNBR $1.68
- EDIT N/A
- P/E Ratio
- SNBR N/A
- EDIT N/A
- Revenue Growth
- SNBR N/A
- EDIT 150.95
- 52 Week Low
- SNBR $8.13
- EDIT $2.35
- 52 Week High
- SNBR $20.75
- EDIT $11.69
- Technical
- Relative Strength Index (RSI)
- SNBR 33.04
- EDIT 30.34
- Support Level
- SNBR $11.26
- EDIT $2.35
- Resistance Level
- SNBR $14.65
- EDIT $3.38
- Average True Range (ATR)
- SNBR 1.13
- EDIT 0.22
- MACD
- SNBR -0.25
- EDIT -0.06
- Stochastic Oscillator
- SNBR 3.26
- EDIT 2.86
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.